Follow the Cannara Biotech Inc. stock price and the full directors' dealings record of the company, a listed issuer based in Canada. Shares are listed on the CA market, under the oversight of SEDI. Market capitalisation: €193.6m. The latest transaction was disclosed on 31 July 2026 (10 - Acquisition or disposition in the public market). Among the most active insiders: Landry, France. The full history is free.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
29Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,959 of 29,024 companies
68.6
score / 100
Value
73
Quality
64
FCF yld6.9%
Earn yld6.7%
EV/EBITDA8.3x
ROE9.7%
Gross mgn44%
Net mgn12%
Debt/EBITDA1.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
16,800 shares@ CA$1.70100.0% of flowCommon SharesTSXSEDI:4731488
Canonical exit: 31 Aug 2026 (T+90)
5 of 5 declarations
About Cannara Biotech Inc.
Cannara Biotech Inc. is a Canadian company focused on the production of cannabis-based products. It is listed on the Toronto Stock Exchange under the symbol XTSE.